<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01421290</url>
  </required_header>
  <id_info>
    <org_study_id>2011/399</org_study_id>
    <nct_id>NCT01421290</nct_id>
  </id_info>
  <brief_title>Treatment of Cartilage Lesions in Flanders Today</brief_title>
  <official_title>Clinical Outcome After Treating Cartilage Defects in the Knee by Surgical or Conservative Means</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is to investigate whether surgical intervention is necessary for&#xD;
      patients who suffer from cartilage lesions of the knee, or whether this surgical intervention&#xD;
      can be avoided or postponed by using conservative treatment options such as physiotherapy,&#xD;
      nutrition supplements, intra-articular injections, bracing.&#xD;
&#xD;
      Forty patients suffering from cartilage lesions in their knee joint will be selected&#xD;
      preoperatively. All these patients fulfil certain inclusion- and exclusion criteria. They&#xD;
      will be asked to respond to 3 different questionnaires. These questionnaires include the&#xD;
      visual analogue scale to evaluate pain (VAS), the Knee injury and Osteoarthritis Outcome&#xD;
      Score or KOOS and the International Knee Documentation Committee (IKDC) form to evaluate the&#xD;
      effect of their cartilage lesion on activities in daily life. Six months later +/- 20&#xD;
      patients will have had surgery and +/- 20 patients will have had conservative treatment, both&#xD;
      groups of patients will be asked to respond again to the 3 different questionnaires. The&#xD;
      outcome of the results will tell us more of the evolution both between groups and in each&#xD;
      group separately.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaires to decide which intervention will be performed.</measure>
    <time_frame>At day 1</time_frame>
    <description>The questionnaires include the visual analogue scale to evaluate pain (VAS), the Knee injury and Osteoarthritis Outcome Score or KOOS and the International Knee Documentation Committee subjective knee form (IKDC) to evaluate the effect of their cartilage lesion on activities in daily life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaires to measure patient satisfaction.</measure>
    <time_frame>At 6 months</time_frame>
    <description>The questionnaires include the visual analogue scale to evaluate pain (VAS), the Knee injury and Osteoarthritis Outcome Score or KOOS and the International Knee Documentation Committee subjective knee form (IKDC) to evaluate the effect of their cartilage lesion on activities in daily life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Lesion of Joint Capsule of Knee Region</condition>
  <arm_group>
    <arm_group_label>Conservative treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>Knee surgery</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conservative comparator</intervention_name>
    <description>Kinesitherapy, intra-articular injection, wearing a brace, thermotherapy, intake of supplements.</description>
    <arm_group_label>Conservative treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic single cartilage lesions of the femur condyles&#xD;
&#xD;
          -  Size of the lesion, determined by MRI:&#xD;
&#xD;
        between 1-2 cm² for the group who will receive conservative treatment between 2-5 cm² for&#xD;
        the group who will have surgery&#xD;
&#xD;
        - Mechanical joint pain, assessed by a 100 mm Visual Analogue Scale: &gt; 40 mm for the&#xD;
        conservative group, &gt; 60 mm for the operative group&#xD;
&#xD;
          -  Agree to stop using analgetics and NSAID's 2 weeks before the First respond of the&#xD;
             surveys, and 2 weeks before the second respond of the surveys. Only paracetamol&#xD;
             (4g/day) is allowed.&#xD;
&#xD;
          -  men and women, women have to use contraceptive to avoid pregnancies.&#xD;
&#xD;
          -  age between 18 - 50 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  participation in concurrent trials&#xD;
&#xD;
          -  participation in previous trials within 3 months&#xD;
&#xD;
          -  subjects with HIV, hepatitis, syphilis&#xD;
&#xD;
          -  malignancy&#xD;
&#xD;
          -  alcohol and drug abuse&#xD;
&#xD;
          -  poor general health condition as judged by the investigator&#xD;
&#xD;
          -  osteochondritis dissecans&#xD;
&#xD;
          -  advanced osteoarthritis (kellgren 2-4)&#xD;
&#xD;
          -  known allergy to penicillins and gentamicin or presence of multiple severe allergies&#xD;
&#xD;
          -  complex ligamentous instability of the knee&#xD;
&#xD;
          -  lateral meniscus lesion or more than 50% resection of medial meniscus&#xD;
&#xD;
          -  Varus or valgus misalignment exceeding 3° (kissing lesions out)&#xD;
&#xD;
          -  Mosaicplasty (OATS)&#xD;
&#xD;
          -  Microfracture performed less than 1 year before baseline&#xD;
&#xD;
          -  Received hyaluronic acid intra-articular injections into the afflicted knee within the&#xD;
             last six months of baseline&#xD;
&#xD;
          -  Taking specific OA drugs, such as chondroitin sulphate, diacerein, capsaicin within&#xD;
             two weeks of the baseline visit&#xD;
&#xD;
          -  Corticosteroid therapy by systemic or intra-articular route within the last month of&#xD;
             baseline or intramuscular or oral corticosteroids within the last two weeks of&#xD;
             baseline&#xD;
&#xD;
          -  Chronic use of anticoagulants&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Any concomitant painful or disabling disease of the spine, hips or lower limbs that&#xD;
             would interfere with evaluation of the afflicted knee&#xD;
&#xD;
          -  Any clinically significant or symptomatic vascular or neurologic disorder of the lower&#xD;
             extremities&#xD;
&#xD;
          -  Any evidence of the following disease in the target joint: septic arthritis,&#xD;
             inflammatory joint disease, hematochrosis, collagen gene mutations&#xD;
&#xD;
          -  Current diagnosis of osteomyelitis&#xD;
&#xD;
          -  A blood result showing liver enzymes more than two times the upper limit of normal or&#xD;
             any other result that in the clinical investigator's mind is important clinically&#xD;
&#xD;
          -  CRP level greater than 10g/l&#xD;
&#xD;
          -  Unwilling to participate in post-operative rehabilitation protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fredrik Almqvist, MD, PhD</last_name>
    <email>fredrik.almqvist@ugent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital, Ghent</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fredrik Almqvist, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>August 17, 2011</study_first_submitted>
  <study_first_submitted_qc>August 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2011</study_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cartilage lesions in the knee joint</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

